Oncodesign Precision Medicine et Navigo Proteins annoncent la fin de leur collaboration dans le développement de radiothéranostiques

Oncodesign Precision Medicine SA published this content on December 29, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on December 29, 2025 at 17:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]